Anti-Cancer Drug Discovery & Development Summit 2002 to take place June 17-19 in Princeton, NJ.

Over twenty-five leading pharmaceutical and biotech companies will present the latest developments at the discovery, preclinical, and clinical stages in the field of oncology at the annual "Anti-Cancer Drug Discovery & Development Summit," in Princeton, NJ on June 17-19, announces Strategic Research Institute.

PRINCETON, NJ, April 25, 2002 --

Over twenty-five leading pharmaceutical and biotech companies will present the latest developments at the discovery, preclinical, and clinical stages in the field of oncology at the annual "Anti-Cancer Drug Discovery & Development Summit," in Princeton, NJ on June 17-19, announces Strategic Research Institute.

This year's meeting will feature presentations on protein kinases, ubiquitin ligases, and epothilones, some of the more promising emerging therapies currently being tested in the clinic. Other topics include anti-mitotic agents, COX-2, proteasome inhibition, thalidomide, telomerase inhibition, vascular targeting, and novel taxanes.

A new addition to this year's meeting is a business development and licensing panel discussion on, "The Oncology Licensing/Deal-Making Climate for 2002-03." The panel will be comprised of representatives from Pfizer, Bristol-Myers Squibb, Pharmacia, OSI Pharmaceuticals, Amgen, and Genentech.

PRESENTERS:

Scientific presentions will be given by Aventis, Pharmacia, Novartis, Bristol-Myers Squibb, Abbott Laboratories, Abgenix, Eli Lilly & Co., OSI Pharmaceuticals, Millennium Pharmaceuticals, Pfizer, Celgene, Geron, Immunex, Keryx Biopharmaceuticals, Signal Research Division of Celgene, National Cancer Institute, Oxigene, Cyclacel, Rigel, Ribozyme Pharmaceuticals, Protarga, Cell Therapeutics, Kosan Biosciences, and Ilex Oncology.

REGISTRATION:

To register, phone 888-666-8514 or 646-336-7030 or online at www.srinstitute.con/cs211.

AGENDA:

To receive the full agenda in PDF format, please contact Jon E. Liong of Strategic Research Institute at jliong@srinstitute.com or 212-967-0095, x243 (please include name, corporate affiliation, mailing address, e-mail, and fax number).

EXPOSITION:

For more information on exposition, or to register as a sponsor please contact Mark Alexay at malexay@srinstitute.com.

VENUE:

June 17-19, 2002
Princeton Marriott
201 Village Boulevard
Princeton, NJ 08540
Tel: 800-228-9290

CONTACT:

Jon E. Liong
Producer, Pharmaceutical Division
Strategic Research Institute
212-967-0095, ext. 243
jliong@srinstitute.com
www.srinstitute.com/cs211